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Epicardial Ventricular Tachycardia Ablation
A Multicenter Safety Study
Frédéric Sacher, MD,*† Kurt Roberts-Thomson, MBBS, PHD,† Philippe Maury, MD,‡
Usha Tedrow, MD,† Isabelle Nault, MD,* Daniel Steven, MD,† Meleze Hocini, MD,*
Bruce Koplan, MD,† Lionel Leroux, MD,* Nicolas Derval, MD,* Jens Seiler, MD,†
Matthew J. Wright, MBBS, PHD,* Laurence Epstein, MD,† Michel Haissaguerre, MD,*
Pierre Jais, MD,* William G. Stevenson, MD†
Bordeaux-Pessac, France; Boston, Massachusetts; and Toulouse, France
Objectives The aim of this study was to perform a systematic evaluation of safety and midterm complications after epicar-
dial ventricular tachycardia (VT) ablation.
Background Epicardial VT ablation is increasingly performed, but there is limited information about its safety and midterm
complications.
Methods All patients undergoing VT ablation at 3 tertiary care centers between 2001 and 2007 were included in this study. Of
913 VT ablations, 156 procedures (17%) involved epicardial mapping and/or ablation. These were performed in 134
patients (109 men; mean age 56  15 years) after a previous VT ablation in 115 (86%). The underlying substrates
were ischemic cardiomyopathy in 51 patients, nonischemic cardiomyopathy in 39 patients, arrhythmogenic right ven-
tricular cardiomyopathy in 14 patients, and other types of cardiomyopathy in 30 patients.
Results Epicardial access was obtained via percutaneous subxiphoid puncture in 136 procedures, by a surgical subxiphoid
approach in 14, and during open-heart surgery in 6. Epicardial ablation (mean radiofrequency duration: 13  12 min;
median: 10 min) was performed in 121 of 156 procedures (78%). Twenty patients subsequently required repeat pro-
cedures, and the epicardium could be reaccessed in all but 1 patient. A total of 8 (5%) major complications related to
pericardial access were observed acutely: 7 epicardial bleeding (80 cm3) and 1 coronary stenosis. After a mean
follow-up period of 23  21 months, 3 delayed complications related to pericardial access were noted: 1 major peri-
cardial inflammatory reaction, 1 delayed tamponade, and 1 coronary occlusion 2 weeks after the procedure.
Conclusions VT ablation required epicardial ablation in 121 of 913 procedures (13%), with a risk of 5% and 2% of acute and
delayed major complications related to epicardial access. (J Am Coll Cardiol 2010;55:2366–72) © 2010 by
the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2009.10.084a
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Padiofrequency (RF) catheter ablation of ventricular tachy-
ardia (VT) in patients with structural heart disease remains
challenging task, with reported success rates not exceeding
3% to 67% from multicenter or large series (n  200)
1–3). One possible limitation of conventional endocardial
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ccepted October 18, 2009.blation techniques is that some re-entry circuits may lie
eep in the subendocardium or in the epicardium, areas
mpossible to access with current endocardial ablation
echniques. Epicardial substrate seems of particular impor-
ance for VT ablation in the setting of nonischemic cardio-
yopathy (CMP) (4) or arrhythmogenic right ventricular
ardiomyopathy (ARVC) but also in patients with ischemic
MP (2,5).
See page 2373
Since 1996 (6), many centers have reported their experi-
nces (4,7–10) with epicardial ablation, but safety and
idterm complications have not been systematically as-
essed in clinical practice.
ethods
opulation and substrate. All patients undergoing VT
blation at 3 tertiary care electrophysiology centers between
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May 25, 2010:2366–72 Epicardial VT Ablation Follow-Up001 and 2007 were included in this study. Of 913 VT
blations, 156 (17%) involved epicardial mapping and/or ab-
ation. They were performed in 134 patients (109 men; mean
ge 56  15 years), after previous failed VT ablation in 115
86%) or because the epicardium was thought to be a likely
ource on the basis of the characteristics of VT in the
emaining patients (Figs. 1 and 2) (11). The underlying
ubstrates were ischemic CMP in 51 patients (38%), non-
schemic CMP in 39 (29%), ARVC in 14 (10%), and other
ypes of CMP (valvular, sarcoidosis, noncompaction of the left
entricle, isolated left ventricular diverticulum) in 13 (10%); 17
atients (13%) had no structural heart disease (Table 1). All
atients had failed therapy with 1 or more antiarrhythmic
rugs.
rocedure. With patients under conscious sedation, the peri-
ardium was mainly accessed via a percutaneous subxiphoid
uncture, as previously described (6), using an epidural needle
Tuohy bevel, 18 gauge, 1.3  80 or 150 mm; Braun,
ronberg, Germany) originally developed to perform epidural
ccess. The needle has a smoothly curved distal end, intended
o facilitate entry into a potential space, and hopefully decreases
he likelihood of a traumatic myocardial puncture. Percutane-
us subxiphoid epicardial access was performed before heparin
Figure 1 12-Lead ECG of Epicardial VT in a Patient With
a Previous Anteroapical Myocardial Infarction
Note that the criteria reported by Berruezo et al. (11) are present for this epi-
sode of ventricular tachycardia (VT) (pseudo–delta wave, intrinsicoid deflection
85 ms, and shortest RS complex 121 ms). ECG  electrocardiogram.nfusion in patients with international normalized ratios2.0. cn cases of previous cardiac surgery
r difficult pericardial access, a sur-
ical subxiphoid (9) (Fig. 3) or
ateral thoracotomy approach was
erformed under general anesthe-
ia. When cardiac surgery was in-
icated for concomitant valvular or
schemic heart disease, ablation
as performed during open-chest
urgery.
The ablation protocols differed
mong centers and evolved dur-
ng the course of the study. Different types of ablation
atheters were used in the pericardium (4- and 8-mm solid
ip, internally and externally irrigated–tip catheters, and
ryocatheters). RF ablation parameters used in the pericar-
ium differed depending on the type of catheter and the
enter. After 2006, externally irrigated–tip catheters
3.5-mm tip, ThermoCool, NaviStar or not; Biosense Web-
ter, Diamond Bar, California) were used at all 3 centers for
picardial RF ablation. Catheter irrigation during epicardial
apping was set at 0 or 1 ml/min. During epicardial
blation, power ranged from 20 to 50 W, with irrigation of
0 to 30 ml/min. Intrapericardial fluid was drained by
spiration from the access sheath periodically after RF
blation lesions or continuously with a vacuum system
onnected to the epicardial sheath, which was 0.5- to 1-F
arger than the ablation catheter.
Before ablation on the left ventricular epicardium, coro-
ary angiography was performed to confirm the absence of
coronary artery at the ablation site. High-output (10 mA
r greater) pacing was also performed before ablation on the
ateral left ventricular wall to exclude close proximity to the
eft phrenic nerve (12). From pericardial access to pericar-
ial sheath removal, a catheter or a guidewire was always
resent, protruding from the sheath, because of concern that
he sharp edge of a pericardial sheath might predispose to
aceration of adjacent tissue or vessels. The pericardial
heath was removed at the end of the ablation in the absence
f pericardial bleeding.
Echocardiography was performed within 24 h after the
rocedure and/or at discharge to assess pericardial fluid. Use
f nonsteroidal anti-inflammatory drugs was left to the
hysician’s discretion.
ata collection. Data were collected from a centralized
ystem containing complete records of all patients treated and
ollowed at the different centers. These records provided
etailed histories and diagnoses for all patients, ablation re-
orts, emergency department visits and outpatient visits, as
ell as data recorded during inpatient care. Patients local to the
ospital were followed up in the ablation center. For the other
atients, referring cardiologists were contacted for clinical
ollow-up and echocardiographic data of their patients. Mor-
ality was assessed from the Social Security Death Index for
merican patients or by direct phone calls to referring physi-
Abbreviations
and Acronyms
ARVC  arrhythmogenic
right ventricular
cardiomyopathy
CMP  cardiomyopathy
RCA  right coronary
artery
RF  radiofrequency
RV  right ventricularians for European patients.
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Epicardial VT Ablation Follow-Up May 25, 2010:2366–72tatistical analysis. Continuous variables are expressed as
ean SD or medians when indicated. Complication and right
entricular (RV) puncture rates of the first 78 procedures com-
ared with the following 78 were compared using Fisher exact
ests. A p value 0.05 was considered statistically significant.
esults
rocedure. A total of 115 patients underwent only 1
ffective epicardial access (percutaneous, surgical, or via
Figure 2 VT in a 61-Year-Old Man With Mild Ischemic Cardiomy
(A) Twelve-lead electrocardiographic morphology of ventricular tachycardia (VT), which
wave, intrinsicoid deflection in lead V2 85 ms). However, no optimal spot could be fou
of the catheter’s position in C. Ablation catheter is in the endocardium while the Pent
dial (ENDO) and epicardial mapping demonstrates that the critical portion of the circui
electrograms recorded on the ablation catheter [using the same amplification], at the
aseline Characteristics of the Population Depending on the SubstTable 1 Baseline Characteristics of the Population Depending
Ischemic CMP
(n  51)
Idio
Percentage of epicardial access compared with the
global population of VT ablation (n  722)
16%
Age (yrs) 63 11
Men 48 (94%)
Left ventricular ejection fraction (%) 31 11
Patients with previous endocardial VT ablation 46 (90%)
Patients with epicardial mapping and ablation 42 (82%)RVC  arrhythmogenic right ventricular cardiomyopathy; CMP  cardiomyopathy; VT  ventricular tachhoracotomy). Sixteen patients had 2 epicardial procedures
nd 3 patients had 3 epicardial procedures with successful
ercutaneous subxiphoid access. However, in 1 other pa-
ient, repeat access failed 3 months after the initial epicardial
rocedure, but she had experienced a dramatic pericardial
eaction after the initial procedure.
The percutaneous subxiphoid approach was successful in
ccessing the pericardial space in 136 procedures and failed in
5 (10%). The reasons for these 15 failures (in 15 different
hy (LVEF: 50%)
ot appear epicardial (EPI) in origin (relatively short QRS complex, no pseudo–delta
he endocardium (normal endocardial voltage). (B) Fluoroscopy (postero-anterior view)
atheter (Biosense Webster) is on the epicardial side of the same area. (C) Endocar-
icardial (50% of the VT cycle length is recorded on the PentaRay catheter, whereas
ponding endocardial spot, are normal). LVEF  left ventricular ejection fraction.
e Substrate
Dilated CMP
 39)
ARVC
(n  14)
No CMP
(n  17)
Other CMP
(n  13)
All Patients
(n  134)
5% 41% 6% 18% 19%
 15 42 13 48 14 53 13 56 15
(82%) 9 (64%) 10 (59%) 10 (77%) 109 (81%)
 12 59 9 61 9 44 11 40 17
(85%) 9 (64%) 15 (88%) 12 (92%) 115 (86%)
(92%) 14 (100%) 12 (71%) 9 (69%) 113 (84%)opat
does n
nd in t
aRay c
t is ep
corresrateon th
pathic
(n
3
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32
33
33
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May 25, 2010:2366–72 Epicardial VT Ablation Follow-Upatients) were histories of cardiac surgery in 11 patients, an
mplantable cardioverter-defibrillator epicardial patch in 1
atient, and histories of pericarditis in 2 patients (including the
atient with a failed repeat procedure). For the remaining
rocedure, the patient had experienced a myocardial infarction
everal years before the procedure, and no clear reason for
ericardial adhesions or failed access was identified.
Concerning the 15 patients from these procedures (with
ailed percutaneous epicardial access), the surgical subxi-
hoid approach was then performed successfully in 9 pa-
ients. No further epicardial attempt was performed in 5
atients, who were not counted further in the study (al-
hough no complications were noted during follow-up, they
id experience VT recurrence). The remaining patient with
ailed access had previously successful percutaneous subxi-
hoid pericardial access and was included in this group for
er first procedure but not counted for her second (failed)
rocedure.
A total of 14 surgical subxiphoid pericardial windows and
thoracotomy procedures were performed for access. Epi-
ardial RF or cryoablation was delivered in 121 of 156
rocedures (78%) (Table 1). Cryoablation was used in 11
rocedures (7%) because of adjacent coronary arteries
n  5) or during open-chest surgery (n  6). In the 35
emaining procedures, no energy was delivered to the
picardium. In 33 procedures, the endocardium was finally
hought to be a better target than the epicardium. In the last
procedures, no ablation was performed, because of the
loseness of the proximal part of the left anterior descending
oronary artery.
Total endocardial and epicardial RF ablation time was
Atrial and
Ventricular
ICD leads
RV ape
Figure 3 Fluoroscopic View During VT Ablation With Surgical S
(Left) Right anterior oblique (RAO) view with an ablation catheter on the site of int
eter (Epi Abl) is placed on the epicardial side of the same spot and has been intro
rior oblique (LAO) view of the same site. CS  coronary sinus catheter; ICD  imp
ventricle; VT  ventricular tachycardia.2  16 min. In the 110 procedures with epicardial RF 1blation, mean epicardial RF duration was 13  12 min
median 10 min). Maximal power varied from 20 to 50 W
median 30 W). Externally irrigated–tip catheters were used
or epicardial ablation in 99 of 156 procedures (63%).
omplications. Major complications (Table 2) were ob-
erved acutely or before discharge in 14 of 156 procedures
9%). Eight were related to epicardial approach (5%): 7
picardial bleeding (80 cm3) because of RV puncture in 4
ases (bleeding stopped spontaneously or after reversal of
eparin anticoagulation; no patient required blood transfu-
ion or surgery) and 1 asymptomatic coronary stenosis in a
rocedure with cryoablation close to a posterolateral ven-
ricular branch of the right coronary artery (RCA). At this
blation site, cryoablation was attempted because of prox-
mity to the coronary artery. Angiography performed after
he 4-min cryoapplication showed a 50% to 60% stenosis.
ollow-up stress testing with single photon-emission com-
uted tomographic perfusion imaging showed that scar
resumably existed before the ablation and was unrelated to
he coronary stenosis.
Six complications were related to endocardial ablation:
ulmonary embolism in 2 patients (in patients with both
enous and arterial femoral access in addition to pericardial
uncture), an audible steam pop with pericardial effusion
uring endocardial ablation in 1 patient (using 35 W with
n irrigated-tip catheter in the RV outflow tract in a
atient with ARVC), cardiogenic shock in 1 patient,
nfranodal atrioventricular block in 1 patient (in a patient
ith idiopathic dilated CMP and epicardial VT as well as
ultiple VTs from the left Purkinje network), and
ilateral groin hematomas requiring blood transfusion in
hoid Access
n the endocardial side (Endo Abl) via a retrograde aortic approach. Another cath-
via surgical approach. Note the surgical spreader (bottom). (Right) Left ante-
le cardioverter-defibrillator; RV apex  catheter placed at the apex of the rightx
ubxip
erest o
duced
lantabpatient (Table 2).
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Epicardial VT Ablation Follow-Up May 25, 2010:2366–72Minor complications (Table 2) related to epicardial access
ere also noted: RV puncture without significant bleeding
80 cm3) in 23 procedures (17% of percutaneous subxi-
hoid access), inadvertent entry of the guidewire into the
leural space without pneumothorax or complication in 2
rocedures (Fig. 3), and chest pain after almost all proce-
ures (related to pericardial inflammation), usually requiring
reatment with nonsteroidal anti-inflammatory drugs. One
inor complication related to endocardial procedure was
lso noted (a femoral artery dissection that did not require
herapy).
To evaluate a possible learning-curve effect on the com-
lication rate, the population was divided into 2 groups
group 1: procedures performed during the first half of the
tudy [initial experience or learning curve] vs. group 2:
rocedures performed during the second half of the study).
o difference was found in terms of major complications
elated or not to pericardial access (3 of 78 during the first
eriod vs. 5 of 78 during the second period, p  NS), but
trend toward more RV punctures (without consequence)
uring the first part of the study was observed (16 of 68
24%] vs. 7 of 68 [10%] with percutaneous subxiphoid
uncture, p  0.07).
ollow-up. After a mean follow-up period of 23  21
onths, 3 of 134 patients (2%) had undergone heart
ransplantation, and 118 of 134 (88%) were still alive.
reedom from VT recurrence was achieved in 95 of 134
atients (71%). Three delayed complications (2%) related to
ericardial access were noted: 1 major pericardial inflamma-
ory reaction, 1 delayed tamponade 10 days after the
rocedure in a patient with a supratherapeutic international
ormalized ratio of 11, and 1 acute inferior myocardial
nfarction 2 weeks after the procedure. This patient had
RVC with epicardial RV free wall ablation, without
receding coronary angiography, which was not routinely
erformed before ablation on the RV epicardial free wall.
cute and Delayed Major and Minor Complications Related to EpicTable 2 Acute and Delayed Major and Minor Complications Re
Complications Related to Epicardial A
Major complications
Acute Intrapericardial bleeding (80 cm3)
Coronary artery stenosis
Delayed (48 h) Major pericardial reaction
Delayed tamponade
Myocardial infarction
Total
Minor complications
RV puncture without consequence 23/136 perc
Pleural catheterization with guidewire 2 /136 (1.5%
Chest pain Almost all pa
V  atrioventricular; RV  right ventricular; VT  ventricular tachycardia.mergency coronary angiography showed RCA occlusion at ihe site of the ablation, with an unusual RCA anatomy (the
arginal branch of the RCA supplying the posterior de-
cending artery).
No constrictive pericarditis or phrenic nerve injuries were
eported in any patient.
iscussion
n this multicenter study, VT ablation required epicardial
blation in 121 of 913 procedures (13%). The overall risk for
cute (5%) and delayed (2%) major complications related to
picardial access and ablation seems justified by the absence
f alternative treatments in this population. However, these
esults must be interpreted in the context of the procedures
eing performed in selected patients and at experienced
enters with acute surgical backup; widespread application
f epicardial access and ablation should progress with
aution.
Consistent with prior reports, the highest prevalence of
picardial VT substrate was observed in patient groups with
iagnoses of ARVC (41%) and nonischemic dilated CMPs
35%), followed by patients with ischemic heart disease
Table 1). Even if these prevalences may be overestimated
ecause of the referral nature of the population (patients
ith epicardial substrate more often referred by other
enters that are not familiar with this technique), the
roportion of epicardial VT substrate in ARVC (13) and
onischemic dilated CMPs (4) is higher compared with
ther substrates.
Although all cardiologists are trained to perform pericar-
ial puncture for tamponade, accessing the pericardium in
he absence of pericardial fluid is more challenging. A
pecific technique has been described by Sosa et al. (6) and
dopted with some variation by electrophysiologists per-
orming such procedures. To prevent major complications,
ome precautions are necessary. First, patient selection is
l and Endocardial VT Ablationto Epicardial and Endocardial VT Ablation
ch Other Complications
4.5%) Pulmonary embolism 2 (1.3%)
0.6%) Endocardial pop with pericardial effusion 1 (0.6%)
Cardiogenic shock 1 (0.6%)
Infranodal AV block 1 (0.6%)
Bilateral groin hematoma requiring
blood transfusion
1 (0.6%)
0.6%)
0.6%)
0.6%)
7%) 6 (4%)
ous approach (17%) Femoral dissection 1 (0.6%)ardialated
pproa
7 (
1 (
1 (
1 (
1 (
11 (
utane
)
tientsmportant. Despite a study by Sosa et al. (14) demonstrating
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May 25, 2010:2366–72 Epicardial VT Ablation Follow-Uphat access can be achieved in some patients who have had
rior cardiac surgery, adhesions may prevent access or limit
apping, RV puncture may be more likely when a potential
ericardial space is not encountered, and coronary artery
ypass grafts may be at risk in some cases. In our study,
ercutaneous subxiphoid pericardial access and/or mapping
ailed in 11 of 13 patients (85%) with previous cardiac
urgery. When access was finally obtained in 2 patients,
apping was limited to the inferior wall.
Second, puncture is facilitated by the use of a Tuohy
eedle to limit the risk for myocardial injury. Use of contrast
edium to confirm entry in the pericardial space and the
ntroduction of a long guidewire, inserted to sufficient
ength to cross multiple cardiac chambers along the cardiac
ilhouette and thus exclude the possibility that it has been
nserted into a cardiac chamber, are mandatory before
ntroducing the sheath. This ensures that myocardial per-
oration or laceration with a large sheath does not occur
Fig. 4). In this study, 20% of RV punctures occurred during
ercutaneous subxiphoid pericardial access, but only 4 (3%)
esulted in significant bleeding. One of these 4 patients had
eceived heparin after transseptal access performed before
picardial access, but there was no additional anticoagula-
ion risk noted for the other 3 patients. Concerning the 3
atients with pericardial bleeding but without RV puncture,
yocardial injury was thought by the operator to be un-
ikely. In 1 of these patients, contrast medium injection
howed a coronary vein shadow, leading to a suspicion of
nadvertent coronary vein puncture. Moreover, to avoid
yocardial wall injury by the sharp edges of a sheath, it
eems reasonable that intrapericardial sheaths should always
ontain either a guidewire and dilator or a catheter and
hould not be left empty in the pericardial space.
Figure 4 Pericardial Access and Complications
(A) Normal pericardial access: posteroanterior view of the heart with a guidewire i
ance is typical of a guidewire correctly placed into the pericardial space. (B) Right
corner with a guidewire (arrows) that does not loop into the pericardium but goes
mediastinum indicates that this has been a difficult pericardial catheterization. Fur
dle. (C) Pleural puncture: lateral view with the guidewire (arrows) in the pleural caThe timing of the epicardial procedure relative to the
ndocardial procedure is also an important issue. It seems
easonable to perform epicardial access before systemic
nticoagulation because of the possibility of bleeding com-
lications. Even though in this study, bleeding always
topped spontaneously or after heparin reversal, caution is
arranted, and on-site surgical backup is advised.
Initially, solid-tip catheters were used for epicardial ab-
ation, but power delivery was limited because of the absence
f cooling from blood flow that is present during endocar-
ial ablation (15). Although externally irrigated–tip cathe-
ers were initially avoided at some centers because of the
eed for intrapericardial fluid infusion, this type of catheter
as subsequently used for epicardial ablation in 63% of our
rocedures, with periodic intrapericardial fluid drainage and
areful monitoring of arterial pressure and motion of the
ardiac silhouette on fluoroscopy (every 15 to 20 min). At
center, fluid was drained continuously with a vacuum
ystem connected to the epicardial sheath during mapping
nd ablation. These investigators also believed that this
pproach improved contact between the catheter tip and the
yocardium.
Because of the risk for coronary artery lesions in the case
f RF application to a vessel, it seemed reasonable to
erform coronary angiography before energy delivery to the
picardium. Because coronary vessels are usually absent
rom the RV free wall, we did not systematically perform
oronary artery angiography at this site. However, even in
he absence of coronary artery lesions in such cases in our
tudy, it could be useful to perform coronary angiography
ven at this site, especially when the catheter position is
oubtful or close to the septal area.
ced through percutaneous subxiphoid access into the pericardium. This appear-
cular puncture: lateral projection with the Tuohy needle in the right bottom
e right ventricle and the pulmonary artery. The contrast staining in the anterior
ore, this compounds the problem by impairing the visualization of the Tuohy nee-ntrodu
ventri
into th
therm
vity.
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Epicardial VT Ablation Follow-Up May 25, 2010:2366–72It is not clear whether epicardial ablation may create
ericardial adherences, but d’Avila et al. (16) suggested
nfusing intrapericardial corticosteroids at the end of the
rocedure to limit this potential risk. In our series, 20
atients had redo epicardial procedures a median of 3
onths after the previous epicardial ablation, with no access
r mapping issues, except for 1 patient in whom it was
mpossible to reaccess the pericardium. This patient had
xperienced a dramatic pericardial reaction after the initial
picardial procedure. No case of constrictive pericarditis was
oted after a mean follow-up period of almost 2 years.
hether the follow-up was too short to develop this
omplication is uncertain, but it would be unlikely that the
isk for constrictive pericarditis after epicardial ablation
xceeds the risk after cardiac surgery, for which it has been
stimated to be 0.2% to 0.3% (17).
Chest pain during the procedure is obviously an issue and
equires powerful analgesia such as fentanyl or sufentanyl in
he absence of general anesthesia. Residual chest pain is also
requent after the procedure, and nonsteroidal anti-
nflammatory drugs are usually prescribed for 1 week.
Our study points out some complications of epicardial
apping and ablation, but other complications have been
eported, such as abdominal bleeding after diaphragmatic
essel injury (8), increased defibrillation threshold due to air
n the pericardium (18), and phrenic nerve injury (12).
ther complications not yet reported may also be antici-
ated, such as lung or mediastinal lesions.
tudy limitations. The study cohort consisted of a highly
elected group of patients with a variety of diagnoses and
nderlying arrhythmia substrates. The majority of the pa-
ients had failed prior endocardial ablation attempts. This
eflected the nature of the referral practice at these 3 tertiary
are electrophysiology centers. It is important to note that
hese findings may not be applicable to less experienced
perators or centers. Percutaneous subxiphoid pericardial
ccess for mapping and/or ablation was started routinely at
ifferent times at the different centers (in 2000 at Brigham
nd Women’s Hospital, in 2004 at Bordeaux University
ospital, and in 2005 at Toulouse University Hospital), but
he pericardial puncture technique itself remained the same
ver the years. The numbers of procedures performed at the
ifferent centers over the study period differed (104 patients
t Brigham and Women’s Hospital, 38 patients at Bordeaux
niversity Hospital, and 14 patients at Toulouse University
ospital). Because of the retrospective nature of the study,
he exact number of RV punctures may be slightly different
rom reality (on the basis of the report).
onclusions
T ablation required epicardial ablation in 121 of 913
rocedures (13%). The risks for acute (5%) and delayed
2%) major complications related to epicardial access seem
ustified by the absence of a therapeutic alternative for this
opulation. Keprint requests and correspondence: Dr. Frédéric Sacher,
ôpital Cardiologique du Haut-Lévêque, 33604 Bordeaux-
essac, France. E-mail: frederic.sacher@chu-bordeaux.fr.
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